Summary of Study ST002843
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001766. The data can be accessed directly via it's Project DOI: 10.21228/M8FB1R This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST002843 |
| Study Title | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) |
| Study Summary | We compared the levels of lipid metabolites in the liver from TgLC and TgL mice with Tamoxifen injection. The lipid metabolites levels in the liver from Balb/c mice bearing C26 or C26-LIF KO tumors were also measured. Mice under both fed and fasted conditions were included. |
| Institute | Rutgers University |
| Last Name | Hu |
| First Name | Wenwei |
| Address | 195 Little Albany St, New Brunswick, NJ 08901 |
| wh221@cinj.rutgers.edu | |
| Phone | 7322356169 |
| Submit Date | 2023-08-23 |
| Study Comments | Same project as Study:ST002824 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzXML |
| Analysis Type Detail | LC-MS |
| Release Date | 2023-11-29 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
| Treatment ID: | TR002962 |
| Treatment Summary: | TgL and TgLC mice were injected with Tamoxifen. Balb/c mice were injected with C26 or C26-LIF KO cells. |
